As the world has focused on the COVID-19 pandemic, other microbial foes are waging war on humans. Antibiotic-resistant bacteria pose a growing threat. But viruses may defeat them.
Antibiotic-resistant bacteria is one of the greatest threats to public health. The bacteria are so pervasive, they’re spilling over to penguins, sea lions, wallabies and more.
Resistant bacteria aren’t the only risk posed by overprescribing antibiotics. A more immediate risk is side-effects and reactions, which a new review shows are surprisingly frequent and often severe.
Estimating the cost of antibiotic resistance to economies and health-care systems is fraught with difficulty, but new research says Australia will be hit harder than we think.
We often think of antibiotic resistance in terms of humans, but it is actually a complex problem of interrelated factors including animal health, the environment and food production.
A CSIRO survey has found many people are confused about common infections, believing antibiotics can treat colds, flu and other viruses. This could fuel a dangerous rise in drug-resistant superbugs.
Finding drugs that treat the COVID-19 coronavirus may be just as important as developing a vaccine. But it’s much harder to create effective antivirals than antibiotics.
Antimicrobial resistance is a public health and economic disaster waiting to happen. If we do not address this threat, by 2050 more people will die from drug-resistant infections than from cancer.
Humans obtain bacteria through the foods they eat. But how do bees collect bacteria that live in and on them? And where do they pick up these microbes?
The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.